ERESEARCHTECHNOLOGY INC /DE/·4

Mar 1, 4:31 PM ET

DEVINE THOMAS P 4

4 · ERESEARCHTECHNOLOGY INC /DE/ · Filed Mar 1, 2010

Insider Transaction Report

Form 4
Period: 2010-02-26
DEVINE THOMAS P
Exec V.P. & Chief Dev Officer
Transactions
  • Award

    Option (Right to Buy)

    2010-02-26$6.05/sh+28,547$172,70928,547 total
    Exercise: $6.05Exp: 2017-02-26Common Stock, $.01 par value (28,547 underlying)
  • Award

    Common Stock, $.01 par value

    2010-02-26+13,63623,636 total
Holdings
  • Option (Right to Buy)

    Exercise: $4.60Exp: 2016-03-02Common Stock, $.01 par value (50,000 underlying)
    50,000
  • Option (Right to Buy)

    Exercise: $12.00From: 2009-02-28Exp: 2015-02-28Common Stock, $.01 par value (7,500 underlying)
    7,500
  • Option (Right to Buy)

    Exercise: $22.09Exp: 2014-02-09Common Stock, $.01 par value (27,000 underlying)
    27,000
  • Option (Right to Buy)

    Exercise: $12.00Exp: 2015-02-28Common Stock, $.01 par value (25,000 underlying)
    25,000
  • Option (Right to Buy)

    Exercise: $6.29Exp: 2013-04-22Common Stock, $.01 par value (43,688 underlying)
    43,688
  • Option (Right to Buy)

    Exercise: $7.41Exp: 2014-02-23Common Stock, $.01 par value (20,000 underlying)
    20,000
  • Option (Right to Buy)

    Exercise: $4.21Exp: 2012-10-22Common Stock, $.01 par value (17,375 underlying)
    17,375
Footnotes (4)
  • [F1]Represents a restricted stock grant that vests in four equal annual installments beginning one year after date of grant.
  • [F2]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable three years prior to expiration.
  • [F3]Options become exercisable in four equal annual installments beginning one year after date of grant and are fully exercisable six years prior to expiration.
  • [F4]25% of the total options granted became exercisable one year after date of grant. The remaining 75% became exercisable in December 2005.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT